ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Voluntary salt-reduction target setting by large food companies: a scoping review and questionnaire survey.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Forecasting Stomach Cancer Burden from High Sodium Intake in Japan, 2022-2050: Scenario Analysis of Demographic Disparities.Nutrients · 2026Article
- Voluntary salt reduction by food companies in Japan: a practical guide to target-setting and reformulation strategies.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dietary salt reduction is essential for the prevention of hypertension. However, food companies often lack reference information for setting appropriate salt-reduction targets. This study aimed to clarify how leading food companies in high-income countries outside Japan establish salt-reduction targets for product reformulation. A scoping review was conducted using PubMed, Google Scholar, and corporate websites. A questionnaire survey was also administered via email to companies with recognized good practices from January to March 2024. The study analyzed the scope of targeted products, salt (including sodium) content criteria, and achievement years, as well as incentives and challenges related to salt reduction. A total of 24 companies and two trade associations were included in the analysis. Among the 40 identified targets, 55% were based solely on salt, while the remaining included multiple nutrients. Regarding reformulation efforts, 68% of targets specified product quantities or proportions, and 55% committed to salt reduction in 33-100% of their products. Furthermore, 65% of the targets set salt criteria by food category; 80% used company-defined salt criteria, while the remaining used government-proposed benchmarks. The median implementation term was five years, with 65% of targets set to be achieved by 2025. Environmental, social, and governance investments were recognized as key incentives. To address reformulation challenges, stepwise approaches based on stakeholder cooperation were proposed. Overall, salt-reduction targets were set within each company's feasible range, considering government policies and global trends. These findings provide a foundation for promoting company-led initiatives to reduce salt intake and contribute to hypertension prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.